Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan W Barnett

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
AIDS Research and Human Retroviruses|December 19, 2002
Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South AfricaJan zur Megede, Susan Engelbrecht, Tulio de Oliveira, et al.
Vaccine|April 13, 2010
Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strainsRachmat Hidajat, Seraphin Kuate, David Venzon, et al.
Vaccine|February 28, 2012
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoproteinAntu K Dey, Brian Burke, Yide Sun, et al.
Virology|October 7, 2008
A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptideGrégoire Martin, Yide Sun, Bernadette Heyd, et al.
Journal of Virology|May 14, 2003
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesJan zur Megede, Gillis R Otten, Barbara Doe, et al.
Virology|June 15, 2007
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogensNina R Derby, Sean Gray, Elizabeth Wayner, et al.
Journal of Virology|August 17, 2006
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infectionNina R Derby, Zane Kraft, Elaine Kan, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Journal of Virology|August 14, 2003
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?Tulio de Oliveira, Susan Engelbrecht, Estrelita Janse van Rensburg, et al.
AIDS Research and Human Retroviruses|February 13, 2002
Characterization of the South African HIV type 1 subtype C complete 5' long terminal repeat, nef, and regulatory genesThomas J Scriba, Tania de Villiers, Florette K Treurnicht, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
AIDS Research and Human Retroviruses|December 19, 2002
Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South AfricaJan zur Megede, Susan Engelbrecht, Tulio de Oliveira, et al.
Vaccine|April 13, 2010
Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strainsRachmat Hidajat, Seraphin Kuate, David Venzon, et al.
Vaccine|February 28, 2012
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoproteinAntu K Dey, Brian Burke, Yide Sun, et al.
Virology|October 7, 2008
A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptideGrégoire Martin, Yide Sun, Bernadette Heyd, et al.
Journal of Virology|May 14, 2003
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesJan zur Megede, Gillis R Otten, Barbara Doe, et al.
Virology|June 15, 2007
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogensNina R Derby, Sean Gray, Elizabeth Wayner, et al.
Journal of Virology|August 17, 2006
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infectionNina R Derby, Zane Kraft, Elaine Kan, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Journal of Virology|August 14, 2003
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?Tulio de Oliveira, Susan Engelbrecht, Estrelita Janse van Rensburg, et al.
AIDS Research and Human Retroviruses|February 13, 2002
Characterization of the South African HIV type 1 subtype C complete 5' long terminal repeat, nef, and regulatory genesThomas J Scriba, Tania de Villiers, Florette K Treurnicht, et al.
Pageof 10